Time-Dependent Inhibition and Estimation of CYP3A Clinical Pharmacokinetic Drug-Drug Interactions Using Plated Human Cell Systems

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drug Metabolism And Disposition

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.112.044644PMID 22490230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism‐Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans

  2011cited by this paper
• Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4.

  2011cited by this paper
• Prediction of CYP3A-Mediated Drug-Drug Interactions Using Human Hepatocytes Suspended in Human Plasma

  2011cited by this paper
• Benzylic oxidation of gemfibrozil-1-O-beta-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition.

  2009influential reference
• The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

  2009influential reference
• Prediction of Human Drug-Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator

  2009cited by this paper
• HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans

  2008cited by this paper
• Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

  2008cited by this paper
• Prediction of Pharmacokinetic Drug-Drug Interactions Using Human Hepatocyte Suspension in Plasma and Cytochrome P450 Phenotypic Data. III. In Vitro-in Vivo Correlation with Fluconazole

  2008cited by this paper
• Prediction of Pharmacokinetic Drug-Drug Interactions Using Human Hepatocyte Suspension in Plasma and Cytochrome P450 Phenotypic Data. II. In Vitro-in Vivo Correlation with Ketoconazole

  2008cited by this paper
• The use of hepatocytes in evaluating time-dependent inactivation of P450 in vivo

  2008influential reference
• Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions

  2007influential reference
• Kinetics of the time-dependent inactivation of CYP2D6 in cryopreserved human hepatocytes by methylenedioxymethamphetamine (MDMA).

  2007cited by this paper
• Sequential Metabolism Is Responsible for Diltiazem-Induced Time-Dependent Loss of CYP3A

  2007cited by this paper
• GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

  2006cited by this paper
• A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation.

  2006influential reference
• The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

  2006influential reference
• EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES

  2006cited by this paper
• Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.

  2006cited by this paper
• EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES

  2005cited by this paper
• Impact of incubation conditions on bufuralol human clearance predictions: enzyme lability and nonspecific binding.

  2004cited by this paper
• Intravenous and oral alfentanil as in vivo probes for hepatic and first‐pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis

  2004influential reference
• Effect of Mibefradil on CYP3A4 In Vivo

  2003cited by this paper
• Pharmacokinetic and Pharmacodynamic Interactions of Oral Midazolam with Ketoconazole, Fluoxetine, Fluvoxamine, and Nefazodone

  2003influential reference
• Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice

  2003influential reference
• Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.

  2000cited by this paper
• An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.

  2000cited by this paper
• Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.

  1999cited by this paper
• Single‐ and Multiple‐dose Mibefradil Pharmacokinetics in Normal and Hypertensive Subjects

  1998cited by this paper
• The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin

  1998cited by this paper
• Inhibition and Induction of Cytochrome P450 and the Clinical Implications

  1998cited by this paper
• Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions.

  1997cited by this paper
• Dose of midazolam should be reduced during diltiazem and verapamil treatments.

  1994cited by this paper
• Cytochrome P450 turnover.

  1991cited by this paper
• Metabolism of benzo[a]pyrene by cultured human hepatocytes from multiple donors.

  1984cited by this paper

• Improvement in static and dynamic projections of drug-drug interactions caused by cytochrome P4503A time-dependent inhibitors through in vitro allosteric modulation by progesterone.

  2024cites this paper
• Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes.

  2023cites this paper
• Induction of CYP450 by illicit drugs: Studies using an in vitro 3D spheroidal model in comparison to animals.

  2022cites this paper
• Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats

  2021cites this paper
• Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes

  2021cites this paper
• DDDT_A_323186 3661..3673

  2021cites this paper
• Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters

  2020cites this paper
• Numerical analysis of time-dependent inhibition kinetics: comparison between rat liver microsomes and rat hepatocyte data for mechanistic model fitting

  2020cites this paper
• Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models

  2020cites this paper
• In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters

  2019cites this paper
• Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

  2019cites this paper
• In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

  2018cites this paper
• A strategy for early-risk predictions of clinical drug–drug interactions involving the GastroPlusTM DDI module for time-dependent CYP inhibitors

  2018cites this paper
• Biotransformation and bioactivation reactions – 2016 literature highlights

  2017cites this paper
• Risk Assessment Using Cytochrome P450 Time-Dependent Inhibition Assays at Single Time and Concentration in the Early Stage of Drug Discovery.

  2017cites this paper
• VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions

  2016influential citation
• Evaluation of Time Dependent Inhibition Assays for Marketed Oncology Drugs: Comparison of Human Hepatocytes and Liver Microsomes in the Presence and Absence of Human Plasma

  2016cites this paper
• Development of an in vitro tool using S9 liver fraction from sheep and goat for the prediction of in vivo drug metabolism and time-dependent kinetics of lincomycin

  2016cites this paper
• N-Alkylated aziridines are easily-prepared, potent, specific and cell-permeable covalent inhibitors of human β-glucocerebrosidase.

  2015cites this paper
• Exploring concepts of in vitro time-dependent CYP inhibition assays

  2014cites this paper
• Reversible mechanisms of enzyme inhibition and resulting clinical significance.

  2014cites this paper
• ABSTRACTS FROM THE 10TH INTERNATIONAL ISSX MEETING

  2014cites this paper
• Assessment of CYP3A4 Time-Dependent Inhibition in Plated and Suspended Human Hepatocytes

  2014cites this paper
• Dynamic Modeling of Cytochrome P450 Inhibition In Vitro: Impact of Inhibitor Depletion on IC50 Shift

  2013cites this paper